Article
FBXO5 acts as a novel prognostic biomarker for patients with cervical cancer
28 Jun 2023
Abstract excerpt
Background: Cervical cancer (CC) remains one of the most common and deadly malignancies in women worldwide. FBXO5, a protein-coding gene, is highly expressed in a variety of primary tumors and promotes tumor progression, however, its role and prognostic value in CC remain largely unknown. Methods: A key differential gene, FBXO5, was screened according to WGCNA based on immunohistochemical assays of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
